Clinical Efficacy of Soft Tissue Trimmer in Cases of Gingival Hyperplasia.
NCT ID: NCT04542486
Last Updated: 2022-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2021-01-28
2021-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of I-PRF After Gingivectomy
NCT07174934
Soft Tissue Wound Healing Following Different Gingivectomy Techniques
NCT03435068
Efficacy of Ceramic Soft Tissue Trimming Bur Versus Conventional Scalpel Technique in Ginigival Depigmentation Procedure
NCT06031116
Efficacy of Hyaluronic Acid Gel and Photobiomodulation on Wound Healing After Surgical Gingivectomy
NCT05787912
Digital Versus Conventional Guided Gingivectomy
NCT05969132
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Following the local anaesthetic administration, A reverse bevel gingivectomy will be performed with a #15c scalpel.
2. The borderline of gingiva will be determined via the use of a pointer dental tweezers, and excessive gingival tissue will then be removed with Gracey curettes
3. No periodontal packs to be applied to ensure accurate evaluations of follow-up pain and wound healing
In the intervention group:
1. Following the local anaesthetics administration for the Soft tissue trimmer(STT) gingivectomies, Soft tissue trimmer will be used with 400-rpm rotary systems and with no serum irrigation, per the manufacturer's recommendation.
2. Gingivoplasties will be performed with the same Soft tissue trimmer to easily provide a knife-edge appearance.
3. No periodontal packs will be applied to ensure accurate evaluations of follow-up pain and wound healing.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The conventional approach:
Gingivoplasties and removal of excess gingival tissues through the conventional scalpel technique using a reverse bevel.
Excision of gingival hyperplasia using the conventional scalpel technique
Excision of gingival hyperplasia in gingivoplasties using the conventional technique reverse bevel using 15c blade.
The intervention approach:
Gingivoplasties and elimination of excess gingival tissues through the use of "Soft tissue trimmer".
Excision of gingival hyperplasia using "Soft tissue trimmer ".
Gingivoplasties and removal of excess gingival tissues using Soft tissue trimmer.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Excision of gingival hyperplasia using "Soft tissue trimmer ".
Gingivoplasties and removal of excess gingival tissues using Soft tissue trimmer.
Excision of gingival hyperplasia using the conventional scalpel technique
Excision of gingival hyperplasia in gingivoplasties using the conventional technique reverse bevel using 15c blade.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age range (18-45) years old
* Plaque-induced inflammatory gingival enlargement
* Altered passive eruption
* No clinical attachment loss
* Systemically healthy individuals
Exclusion Criteria
* Pregnancy and/or lactation
* Allergy
* Conditions requiring antibiotic prophylaxis and anti-inflammatory medications.
* Acute or untreated periodontitis
* Systemic disease that could influence the outcome of the treatment (i.e. Diabetes)
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mai Mohamed Sameh
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Oral and Dental Medicine-CU
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PER 3-3-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.